1. Home
  2. KINS vs TVGN Comparison

KINS vs TVGN Comparison

Compare KINS & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KINS
  • TVGN
  • Stock Information
  • Founded
  • KINS 1886
  • TVGN 2020
  • Country
  • KINS United States
  • TVGN United States
  • Employees
  • KINS N/A
  • TVGN N/A
  • Industry
  • KINS Property-Casualty Insurers
  • TVGN Blank Checks
  • Sector
  • KINS Finance
  • TVGN Finance
  • Exchange
  • KINS Nasdaq
  • TVGN Nasdaq
  • Market Cap
  • KINS 189.6M
  • TVGN 179.0M
  • IPO Year
  • KINS N/A
  • TVGN N/A
  • Fundamental
  • Price
  • KINS $14.75
  • TVGN $0.72
  • Analyst Decision
  • KINS
  • TVGN Strong Buy
  • Analyst Count
  • KINS 0
  • TVGN 1
  • Target Price
  • KINS N/A
  • TVGN $10.00
  • AVG Volume (30 Days)
  • KINS 140.2K
  • TVGN 555.8K
  • Earning Date
  • KINS 10-28-2025
  • TVGN 11-18-2025
  • Dividend Yield
  • KINS 1.36%
  • TVGN N/A
  • EPS Growth
  • KINS 325.10
  • TVGN N/A
  • EPS
  • KINS 2.04
  • TVGN N/A
  • Revenue
  • KINS $183,702,376.00
  • TVGN N/A
  • Revenue This Year
  • KINS $41.35
  • TVGN N/A
  • Revenue Next Year
  • KINS $12.33
  • TVGN N/A
  • P/E Ratio
  • KINS $7.23
  • TVGN N/A
  • Revenue Growth
  • KINS 28.36
  • TVGN N/A
  • 52 Week Low
  • KINS $8.45
  • TVGN $0.26
  • 52 Week High
  • KINS $22.40
  • TVGN $3.09
  • Technical
  • Relative Strength Index (RSI)
  • KINS 52.30
  • TVGN 37.35
  • Support Level
  • KINS $14.23
  • TVGN $0.64
  • Resistance Level
  • KINS $15.21
  • TVGN $0.76
  • Average True Range (ATR)
  • KINS 0.42
  • TVGN 0.06
  • MACD
  • KINS 0.05
  • TVGN -0.00
  • Stochastic Oscillator
  • KINS 62.40
  • TVGN 32.73

About KINS Kingstone Companies Inc.

Kingstone Companies Inc is a multi-line regional property and casualty insurance holding company. It offers insurance policies to small and mid-sized businesses as well as to individuals.

About TVGN Tevogen Bio Holdings Inc. Common Stock

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.

Share on Social Networks: